BURGESS DANIEL D
Insider CIK 1239650 · SNTS Director · ABUS Director · CDTX Director · NBRV Director · NBRV Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 1,400 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 875 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 550 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 450 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 11,100 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 20,500 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer deriv | 2026-01-07 | 2026-01-07 | 2,125 | — | $0 | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | D To issuer | 2026-01-07 | 2026-01-07 | 150 | $221.50 | $33.2K | 0 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2025-06-18 | 2025-06-18 | 11,100 | — | $0 | 11,100 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-12-17 | 2024-12-19 | 20,500 | — | $0 | 20,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2024-07-18 | 2024-07-19 | 2,125 | — | $0 | 2,125 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2024-05-23 | 2024-05-24 | 67,000 | — | $0 | 67,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2023-06-22 | 2023-06-23 | 42,500 | — | $0 | 42,500 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2023-05-24 | 2023-05-26 | 55,000 | — | $0 | 55,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2022-08-02 | 2022-08-04 | 11,341 | $0.19 | $2.2K | 10,384 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2022-06-22 | 2022-06-24 | 28,000 | — | $0 | 28,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2022-05-25 | 2022-05-26 | 41,000 | — | $0 | 41,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | S Sale | 2021-08-02 | 2021-08-04 | 1,125 | $1.20 | $1.4K | 21,725 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2021-07-28 | 2021-07-30 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2021-07-28 | 2021-07-30 | 17,500 | — | $0 | 22,850 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2021-06-23 | 2021-06-24 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2021-06-03 | 2021-06-07 | 22,000 | — | $0 | 22,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2020-07-29 | 2020-07-31 | 35,000 | — | $0 | 35,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award | 2020-07-29 | 2020-07-31 | 17,500 | — | $0 | 53,500 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2020-06-25 | 2020-06-25 | 17,500 | — | $0 | 17,500 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2020-05-28 | 2020-06-01 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2019-08-17 | 2019-08-20 | 22,000 | — | $0 | 22,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2019-07-31 | 2019-08-01 | 35,000 | — | $0 | 35,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2019-06-17 | 2019-06-27 | 11,000 | — | $0 | 11,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-08-01 | 2018-08-02 | 15,000 | — | $0 | 15,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | P Buy | 2018-07-31 | 2018-08-02 | 36,000 | $2.75 | $99.0K | 36,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2018-06-19 | 2018-06-22 | 22,000 | — | $0 | 22,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2018-06-13 | 2018-06-15 | 11,000 | — | $0 | 11,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2018-05-02 | 2018-05-04 | 29,000 | — | $0 | 29,000 | SEC↗ |
| NBRV Nabriva Therapeutics plc | A Award deriv | 2017-09-15 | 2017-09-19 | 10,100 | — | $0 | 10,100 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 10,100 | — | $0 | 10,100 | SEC↗ |
| NBRV Nabriva Therapeutics Plc | J Other deriv | 2017-06-23 | 2017-06-27 | 20,200 | — | $0 | 20,200 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2017-06-22 | 2017-06-23 | 11,000 | — | $0 | 11,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2017-06-21 | 2017-06-22 | 22,000 | — | $0 | 22,000 | SEC↗ |
| ABUS Arbutus Biopharma Corp | A Award deriv | 2017-03-24 | 2017-03-27 | 50,000 | — | $0 | 50,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2016-06-22 | 2016-06-24 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | A Award deriv | 2015-06-09 | 2015-06-11 | 9,000 | — | $0 | 9,000 | SEC↗ |
| CDTX Cidara Therapeutics, Inc. | P Buy | 2015-04-20 | 2015-04-21 | 3,000 | $16.00 | $48.0K | 3,000 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 40,000 | $22.00 | $880.0K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 37,000 | $25.27 | $935.0K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 37,000 | $10.07 | $372.6K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 37,000 | $29.53 | $1.09M | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 32,000 | $28.67 | $917.4K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 37,000 | $28.88 | $1.07M | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 35,000 | $25.27 | $884.5K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 37,000 | $26.68 | $987.2K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 37,000 | $29.98 | $1.11M | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 12,000 | $30.82 | $369.8K | 0 | SEC↗ |
| SNTS SANTARUS INC | D To issuer deriv | 2014-01-02 | 2014-01-06 | 37,000 | $29.62 | $1.10M | 0 | SEC↗ |
| SNTS SANTARUS INC | A Award deriv | 2013-06-11 | 2013-06-12 | 37,000 | — | $0 | 37,000 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-06-03 | 2013-06-04 | 8,000 | — | $0 | 0 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-06-03 | 2013-06-04 | 8,000 | $21.34 | $170.7K | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-06-03 | 2013-06-04 | 8,000 | $3.00 | $24.0K | 8,000 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-05-01 | 2013-05-02 | 8,000 | — | $0 | 8,000 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-05-01 | 2013-05-02 | 8,000 | $3.00 | $24.0K | 8,000 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-05-01 | 2013-05-02 | 8,000 | $17.88 | $143.0K | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-04-01 | 2013-04-02 | 4,000 | — | $0 | 16,000 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-04-01 | 2013-04-02 | 4,000 | — | $0 | 12,000 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-04-01 | 2013-04-02 | 4,000 | $3.00 | $12.0K | 8,000 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-04-01 | 2013-04-02 | 8,000 | $17.47 | $139.8K | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-04-01 | 2013-04-02 | 4,000 | $1.18 | $4.7K | 4,000 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-03-01 | 2013-03-04 | 8,000 | — | $0 | 16,000 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-03-01 | 2013-03-04 | 8,000 | $1.18 | $9.4K | 8,000 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-03-01 | 2013-03-04 | 8,000 | $13.37 | $107.0K | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise deriv | 2013-02-01 | 2013-02-04 | 8,000 | — | $0 | 24,000 | SEC↗ |
| SNTS SANTARUS INC | S Sale | 2013-02-01 | 2013-02-04 | 8,000 | $13.28 | $106.2K | 0 | SEC↗ |
| SNTS SANTARUS INC | M Exercise | 2013-02-01 | 2013-02-04 | 8,000 | $1.18 | $9.4K | 8,000 | SEC↗ |
| SNTS SANTARUS INC | A Award deriv | 2012-06-13 | 2012-06-14 | 37,000 | — | $0 | 37,000 | SEC↗ |